Discovering an unknown territory using atom probe tomography: Elemental exchange at the bioceramic scaffold/bone...

Current understanding of bioceramic implants in bone repair remains limited, particularly regarding how these materials influence the chemical composition of newly formed bone tissue. While prior research has shown that bioceramics can support bone regeneration, the specific interactions at the atomic scale between implants and bone tissue are not well characterized. Existing studies have focused on macroscopic outcomes such as bone growth and mechanical integration, but lack detailed insights into elemental exchange at the interface. This gap motivated the use of advanced imaging techniques to explore the nanoscale chemical changes occurring at the bioceramic-bone interface. No prior work has resolved the precise distribution of trace elements from degrading implants into surrounding tissue. Understanding these processes is crucial for improving implant design and predicting long-term performance. The need for high-resolution spatial chemical mapping has driven the adoption of atom probe tomography and nanoSIMS in recent studies. These tools allow researchers to visualize elemental transport at the nanoscale, offering new perspectives on how bioceramics integrate with bone. This paper addresses a key limitation in the field by combining two complementary imaging methods to study in vivo bone formation.

The aim of this study was to investigate the atomic-scale chemical composition of bone tissue formed in a bioceramic scaffold after long-term implantation in a sheep tibia. The specific problem addressed is the lack of knowledge about how bioceramic implants influence the elemental composition of newly formed bone and surrounding mature bone tissue. The motivation stems from the need to improve bioceramic scaffold design by understanding how elements from the implant are released and transported into bone. This study focuses on a specific bioceramic material—strontium-hardystonite-gahnite—and its interaction with bone tissue after 12 months of implantation. The goal is to determine whether elements from the bioceramic, such as aluminium, are present in newly formed bone and how they are distributed. The study also seeks to confirm the transport mechanisms of these elements from the implant into bone tissue. By combining atom probe tomography with nanoSIMS, the researchers aimed to achieve precise spatial resolution of elemental distributions. This approach allows for a detailed assessment of how bioceramics interact with bone at the nanoscale, which is essential for optimizing future implant designs.

The study employed atom probe tomography to analyze the atomic-scale composition of bone tissue formed in a bioceramic scaffold implanted in a sheep tibia for 12 months. This technique allows for the detection and mapping of individual atoms within a material, providing high-resolution chemical data. Complementary nanoSIMS mapping was used to confirm the spatial distribution of elements released from the bioceramic into the surrounding bone tissue. The combination of these two methods enabled the researchers to assess both the composition and localization of trace elements at the tissue-biomaterial interface. The bioceramic scaffold used in the study was composed of strontium-hardystonite-gahnite, a material known for its potential in bone regeneration. The implantation site was selected based on a large bone defect in the sheep tibia, ensuring a relevant in vivo model for studying bone formation. The samples were prepared for atom probe analysis using focused ion beam milling to create a sharp tip suitable for high-resolution imaging. The nanoSIMS technique provided additional confirmation of elemental transport patterns observed in the atom probe data. These methods together allowed for a comprehensive assessment of the chemical interactions between the bioceramic and bone tissue.

The atom probe tomography revealed that the newly formed bone tissue within the bioceramic scaffold had a different composition compared to mature cortical bone tissue. Elements from the degrading bioceramic implant, particularly aluminium, were detected in both the newly formed bone and the surrounding mature bone tissue. The presence of aluminium suggests that elements from the bioceramic are released and transported into the bone tissue. NanoSIMS mapping confirmed the spatial distribution of these released ions within the scaffold and surrounding tissue. The study demonstrated that trace elements from the bioceramic are actively transported into the newly formed bone. The combined use of atom probe tomography and nanoSIMS provided precise localization of elemental changes at the scaffold-bone interface. These findings indicate that bioceramic implants influence the chemical composition of newly formed bone. The data also suggest that the transport of elements from the implant into bone tissue is an active process rather than passive diffusion. These results provide the first detailed insight into the nanoscale chemical interactions between bioceramics and bone tissue.

The study confirmed that elements from the bioceramic scaffold are released and transported into newly formed bone tissue, as observed through atom probe tomography and nanoSIMS. The presence of aluminium in both newly formed and mature bone tissue suggests that the bioceramic influences the chemical composition of bone. The researchers propose that the transport of elements from the implant into bone is an active process, which could impact bone regeneration outcomes. The combination of atom probe tomography and nanoSIMS proved effective in mapping elemental distributions at the scaffold-bone interface. These findings provide a foundation for understanding how bioceramics interact with bone at the nanoscale. The study highlights the importance of considering elemental exchange when designing bioceramic implants. The authors suggest that these insights could lead to iterative improvements in scaffold design and performance. The results may also help in reducing the risk of implant failure and increasing the rate of tissue formation in future applications.